Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

full operations and the full financial impact of these events. NCH will take a one-time charge currently estimated at USD 120 million in the fourth quarter of 2011, relating to the recalls and improvement work at the Lincoln, NE facility.

Novartis commitment to qualityThe Novartis Group is fully committed to ensuring the quality, safety and integrity of its products. All Novartis Group companies have a clear commitment to patients and Health Authorities to ensure high quality standards for all our products and services. Novartis Group companies stand behind the safety and efficacy of their products, and are fully committed to maintaining high quality standards at all production sites in the US and around the world. All Novartis Group products are subjected to strict manufacturing, testing and monitoring standards. Where they fall outside the standards, Novartis Group companies take actions to correct the issue and may recall products as a precaution.

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "potential," "will," "committed," "commitment," "plans," or similar expressions, or by express or implied discussions regarding the potential length of the shutdown of our Lincoln, NE production facility, regarding the potential for any further regulatory actions at the Lincoln, NE production facility, regarding the potential for any further quality issues arising at any additional Novartis manufacturing facilities, or regarding the potential financial impact of the Lincoln, NE facility shutdown. You should not place undue reliance on these statements.  Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no gua
'/>"/>

SOURCE Novartis Consumer Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Minn. , March 4, 2015   Mayo ... an agreement to develop the next generation of wearable ... "We are hoping that this technology will be game-changer. ... and diabetes," says James Levine, M.D., Ph.D. , ... "They are accurate, inexpensive, and can be integrated into ...
(Date:3/4/2015)... KANSAS CITY, Kan. , March 4, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the licensing, ... animals, today announced that it will present at the ... March 10-12, 2015, at the Loews Miami Beach Hotel ... Steven St. Peter , M.D., President and ...
(Date:3/4/2015)... -- From March 8-11, 2015 Excellis Health Solutions ... and Expo in Orlando, Florida ... education event, attended by nearly 500 manufacturers, distributors, ... distribution industry moving. Attracting thought-provoking speakers, programming puts ... to healthcare distribution and technology, logistics and market ...
Breaking Medicine Technology:Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2
... Support Development,of Omega DUROS Continuous Delivery Therapy, ... Intarcia,Therapeutics, Inc., a privately held biopharmaceutical company,today ... study of omega,interferon with or without ribavirin ... C. The results demonstrate that,omega interferon in ...
... Conn., April 12, 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation ... (PXD101), a histone deacetylase (HDAC) inhibitor being,investigated ... a protein,being investigated for the prevention of ... upcoming American Association for Cancer,Research (AACR) 2007 ...
Cached Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4
(Date:3/4/2015)... York, NY (PRWEB) March 04, 2015 ... WaterAid a total of $6.9 million, which ... Ghana, Mali, Niger and Burkina Faso. , The programs ... areas. The first will focus on fixing water points ... the skills of local people to maintain water points ...
(Date:3/4/2015)... 2015 Nike Swim Camps offer outstanding ... mission is to stimulate a love of swimming in ... provide campers the opportunity to train with some of ... Merrion, Vice President of US Sports Camps. “Our program ... to build confidence and improve their technique.” , Nike ...
(Date:3/4/2015)... Columbus, Ohio (PRWEB) March 04, 2015 ... as an ingredient in premium sports nutrition products, is ... Greatest Trainer booth in the Terrace Ballroom at The ... place from March 5, 2015 to March 8, 2015. ... arginine silicate with FDA New Dietary Ingredient notification status; ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, H1 2015? ... Vasculitis is a disease that features tenderness of the ... not known. Vasculitis can affect any body system and ... include fever, weight loss, tiredness, aches, pains, night sweats, ... Vasculitis is treatable, but it is not curable. The ...
(Date:3/4/2015)... 04, 2015 The week of March ... with World Sleep Awareness Day being recognized on March ... health and financial risks associated with sleep related illnesses, ... Apnea Treatment Centers of America have turned to social ... they hope will virally inspire conversation regarding the disease. ...
Breaking Medicine News(10 mins):Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4
... University of Melbourne have discovered the local action of ... of viral skin infections. , This work identifies previously ... barrier locations such as the skin and the gut, ... bacteria. , Researchers examined two aspects of anti-viral immune ...
... - Portable USB Device Will Expedite Emergency Responders, ... 7 eMed-ID, the world,s first medical identification ... that will expedite emergency responders treatment of trauma ... expanding its national footprint with today,s announcement that ...
... Shamir Optical Industry Ltd. (Nasdaq: SHMR ... technology to the ophthalmic lens market, today announced that the ... that the Company no longer complies with the audit committee ... requires a listed company to have an audit committee of ...
... 7 HIMSS -- Infotech Global, Inc. (IGI) announced ... Health, a not-for-profit health system in Central New Jersey ... Transfer Form (UTF). The draft UTF was tested with ... in 2008. This work was made possible through the ...
... are at risk of developing the eye disease ROP ... from the Sahlgrenska Academy, University of Gothenburg, Sweden, suggests ... for considerably more expensive ophthalmological examinations. , Every year ... months prematurely. Preterm infants are at increased risk of ...
... DARTMOUTH, NS, April 7 /PRNewswire/ - A new study ... AACR (American Association for Clinical Cancer Research), shows diets ... acid) may decrease the risk of prostate cancer. This ... with a genetic tendency towards developing the disease. , ...
Cached Medicine News:Health News:Not just a long-distance relationship: Immune cells in skin fight off infection better than the rest 2Health News:eMed-ID, World's First Medical Identification Franchise, Opens Tampa Bay Market for Franchise Sales 2Health News:eMed-ID, World's First Medical Identification Franchise, Opens Tampa Bay Market for Franchise Sales 3Health News:Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Noncompliance with Nasdaq Audit Committee Composition Requirements 2Health News:Meridian Health Pilots Electronic Transfer Form 2Health News:Meridian Health Pilots Electronic Transfer Form 3Health News:New, simple method identifies preterm infants at risk of eye disease 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 3
... visual field testing that's so efficient it,can ... first visual field instrument that's simple enough, ... used even in pre-test. Affordably priced FDT ... behind it to validate performance. The instrument ...
... Simple operation + Quick results. The ... Operational procedure that create a system of ... reduces patient fatigue, ,Within a compact, ... AP-340 incorporates numerous function and features.The integration ...
... EXCLUDER AAA Endoprosthesis is an innovative device ... option for patients with abdominal aortic aneurysms ... ePTFE bifurcated graft with an outer self-expanding ... flexibility and material durability. The function of ...
... a cast saw to remove a cast from ... in patients. Occasionally patients are cut or burned ... Strip enables healthcare professionals to remove any cast ... provides protection against cuts and burns from the ...
Medicine Products: